Literature DB >> 25269746

Upregulated microRNA-199a-5p inhibits nuclear receptor corepressor 1 translation in mice with non‑alcoholic steatohepatitis.

Binggui Zhang1, Rongqi Wang1, Jinghua Du1, Jingya Niu2, Rui Zhang3, Shunjiang Xu3, Xuemin Niu1, Qingfu Zhang3, Yuemin Nan1.   

Abstract

Mounting evidence indicates that dysregulated microRNAs (miRNAs) are important in the etiology and pathogenesis of steatohepatitis. However, the functions of miRNAs in the pathophysiological process of non-alcoholic steatohepatitis (NASH) are poorly understood. In this study, C57BL/6J mice were fed a methionine-choline‑deficient (MCD) diet for eight weeks in order to induce hepatic steatohepatitis. Using reverse transcription polymerase chain reaction, the hepatic expression levels of miR-199a-5p, miR-122 and miR-221 in the mice were examined. Bioinformatic analysis of dysregulated miR-199a-5p was performed to predict the potential role of miR‑199a‑5p in NASH. The MCD diet was found to significantly reduce miR-122 expression levels and significantly increase miR‑199a-5p expression levels in mouse livers, compared with those of mice fed a control diet. In the bioinformatic analysis, miR‑199a‑5p was identified to be predominantly involved in transcription, protein serine/threonine kinase activity, insulin signaling, and the Wnt and mitogen‑activated protein kinase signaling pathways. The regulation of nuclear receptor corepressor 1 (NCOR1) by miR‑199a-5p was also examined by silencing and overexpressing this miRNA in LX-2 cells. The data revealed that NCOR1 protein levels were significantly reduced and enhanced by miR-199a-5p mimic and inhibitor, respectively. These findings suggest a key role for miR-199a-5p in the progression of NASH through inhibition of NCOR1 translation, and provide novel insights into NASH pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269746     DOI: 10.3892/mmr.2014.2592

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Xi Jin; Jiang Liu; Yi-Peng Chen; Zun Xiang; Jie-Xia Ding; You-Ming Li
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

2.  Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.

Authors:  Mei Han; Weronika Piorońska; Sai Wang; Zeribe Chike Nwosu; Carsten Sticht; Shanshan Wang; Yan Gao; Matthias Philip Ebert; Steven Dooley; Christoph Meyer
Journal:  Cell Death Dis       Date:  2020-02-06       Impact factor: 8.469

3.  Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades.

Authors:  Zhichao Liu; Yuping Wang; Jürgen Borlak; Weida Tong
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

4.  miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy.

Authors:  Bo Li; Xiangsong Wu; Hanbei Chen; Chengle Zhuang; Zhiguo Zhang; Shuangshuang Yao; Dongsheng Cai; Guang Ning; Qing Su
Journal:  Cell Death Dis       Date:  2018-03-14       Impact factor: 8.469

5.  Assigning mitochondrial localization of dual localized proteins using a yeast Bi-Genomic Mitochondrial-Split-GFP.

Authors:  Gaétan Bader; Ludovic Enkler; Yuhei Araiso; Marine Hemmerle; Krystyna Binko; Emilia Baranowska; Johan-Owen De Craene; Julie Ruer-Laventie; Jean Pieters; Déborah Tribouillard-Tanvier; Bruno Senger; Jean-Paul di Rago; Sylvie Friant; Roza Kucharczyk; Hubert Dominique Becker
Journal:  Elife       Date:  2020-07-13       Impact factor: 8.140

6.  Integrated microRNA and proteome analysis reveal a regulatory module in hepatic lipid metabolism disorders in mice with subclinical hypothyroidism.

Authors:  Liya Zhang; Kunpeng Wu; Tao Bo; Lingyan Zhou; Ling Gao; Xiaoming Zhou; Wenbin Chen
Journal:  Exp Ther Med       Date:  2019-12-04       Impact factor: 2.447

Review 7.  Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases.

Authors:  Martin A Geiger; Ana T Guillaumon; Francesco Paneni; Christian M Matter; Sokrates Stein
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.